Melanocytic naevi, other sites/unspecified

DOID EFO MESH PheWeb

CD2_BENIGN_MELANOCYTIC_NOS

brain neoplasm: A neoplasm (disease) that involves the brain.

Endpoint definition

↥

FinnGen phenotype data

321302 individuals

Apply sex-specific rule None

321302

Check conditions None

321302

Filter registries

Hospital Discharge: ICD-10 D22.9&

Hospital discharge: ICD-9 216[8-9]A

Hospital discharge: ICD-8 $!$

Cause of death: ICD-10 D22.9&

Cause of death: ICD-9 216[8-9]A

Cause of death: ICD-8 $!$

1403

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10, 8, 9 ; C.O.D: 10, 8, 9

1403

Check minimum number of events None

1403

Include endpoints None

1403

CD2_BENIGN_MELANOCYTIC_NOS

Extra metadata

Level in the ICD hierarchy 3

First used in FinnGen datafreeze DF2

Parent code in ICD-10 D22

Name in latin Naevus melanocyticus non specificatus

Similar endpoints

↥

List of similar endpoints to Melanocytic naevi, other sites/unspecified based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

None

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	1372	841	531
Unadjusted prevalence (%)	0.44	0.48	0.39
Mean age at first event (years)	50.54	46.99	56.16

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	0.04	3.15 [1.71, 5.80]	2.3e-4	52
15 years	0.01	1.89 [0.95, 3.76]	6.8e-2	29
5 years	0.00	2.37 [1.18, 4.78]	1.5e-2	14
1 year	-	-	-	-

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: CD2_BENIGN_MELANOCYTIC_NOS – Melanocytic naevi, other sites/unspecified
GWS hits: 0

Survival analyses between endpoints

↥

Plot

before Melanocytic naevi, other sites/unspecified
after Melanocytic naevi, other sites/unspecified

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Melanocytic naevi, other sites/unspecified

↥